Mark Hahn

Mark Hahn

Direktör/Styrelseledamot på ALSP ORCHID ACQUISITION CORPORATION I
63 år
Health Technology
Communications
Technology Services

Profil

Mark W.
Hahn
is an Independent Director at ALSP Orchid Acquisition Corp.
I since 2021.
Mr. Hahn is a Director at Opterion Health AG.
Former roles include Independent Director at Soleno Therapeutics, Inc. from 2025 to 2026; Chief Financial Officer at Charles & Colvard Ltd. from 1984 to 1996; Chief Financial Officer, Secretary & Treasurer at Verona Pharma Ltd.; Chief Financial Officer at Equitel, Inc.; Principal at Ernst & Young LLP; Chief Financial Officer at Athenix Corp.
from 2008 to 2009; Chief Financial Officer & VP-Administration at Gigabeam Corp.
from 2007 to 2008; Chief Financial Officer at BuildLinks, Inc. from 2002 to 2007; Chief Financial Officer & Executive Vice President at Cempra Pharmaceuticals, Inc. and Cempra, Inc. from 2010 to 2017; Chief Financial Officer at Performaworks, Inc.; and Chief Financial Officer at Dova Pharmaceuticals, Inc. from 2018 to 2019.
Education includes an undergraduate degree from the University of Wisconsin-Milwaukee conferred in 1984.

Aktiva positioner av Mark Hahn

FöretagPositionStart
ALSP ORCHID ACQUISITION CORPORATION I Direktör/Styrelseledamot 2021-11-01
Direktör/Styrelseledamot -

Tidigare kända positioner av Mark Hahn

FöretagPositionSlut
SOLENO THERAPEUTICS, INC. Direktör/Styrelseledamot 2026-05-15
DOVA PHARMACEUTICALS, INC. Finansdirektör/CFO 2019-11-12
Finansdirektör/CFO 2017-11-30
Finansdirektör/CFO 2017-11-01
Finansdirektör/CFO 2009-01-01
Se detaljerna i Mark Hahns erfarenhet

Mark Hahns utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

50

Första gradens relationer

15

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag15

Consumer Durables

Communications

Commercial Services

Process Industries

Communications

Technology Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Consumer Services

Health Technology

Health Services

Finance